Multiple Ascending Dose Study of PRX002 in Patients With Parkinson's Disease
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This multiple ascending dose study is to determine safety, tolerability, pharmacokinetics and
immunogenicity of PRX002 in approximately 60 patients with Parkinson's disease.